MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
Stock Snapshot
With a market cap of 1.27B, MannKind(MNKD) trades at $3.90. The stock has a price-to-earnings ratio of -27.52.
As of 2026-10-01, MannKind(MNKD) stock has fluctuated between $3.80 and $4.23. The current price stands at $3.90, placing the stock +2.6% above today's low and -7.7% off the high.
The MannKind(MNKD)'s current trading volume is 10.19M, compared to an average daily volume of 6.33M.
In the last year, MannKind(MNKD) shares hit a 52-week high of $6.51 and a 52-week low of $2.23.
In the last year, MannKind(MNKD) shares hit a 52-week high of $6.51 and a 52-week low of $2.23.
MNKD News
MannKind (MNKD) has drawn fresh attention after a sharp 16.8% one day gain, followed by an 18.5% advance over the past week, raising questions about what this m...
Liquidia’s (LQDA) Yutrepia faces a Delaware court finding of infringement of United Therapeutics’ (UTHR) ‘327 patent, pressuring Liquidia shares but providing a...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.